Search

Your search keyword '"Sven Seys"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Sven Seys" Remove constraint Author: "Sven Seys" Topic medicine.disease Remove constraint Topic: medicine.disease
56 results on '"Sven Seys"'

Search Results

1. How to detect young athletes at risk of exercise-induced bronchoconstriction?

2. Exposome mapping in chronic respiratory diseases: the added value of digital technology

3. Tackling nasal symptoms in athletes: Moving towards personalized medicine

4. Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation

5. Toward clinically applicable biomarkers for asthma: An <scp>EAACI</scp> position paper

6. Dermal exposure determines the outcome of repeated airway exposure in a long-term chemical-induced asthma-like mouse model

7. Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement

8. Innate lymphoid cells in asthma: pathophysiological insights from murine models to human asthma phenotypes

9. Lacticaseibacillus casei AMBR2 restores airway epithelial integrity in chronic rhinosinusitis with nasal polyps

10. Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity

11. Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years

12. Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma

13. Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA

14. Mechanisms of exercise‐induced bronchoconstriction in athletes: Current perspectives and future challenges

15. Role of sputum biomarkers in the management of asthma

16. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre

17. EUFOREA consensus on biologics for CRSwNP with or without asthma

18. Intranasal probiotic Lactobacillus rhamnosus GG prevents respiratory exacerbation in a mouse model of birch pollen allergic asthma

19. Staphylococcus aureus Enterotoxin B Disrupts Nasal Epithelial Barrier Integrity via TLR2 Activation

20. Full Patient Monitoring Using Digital Health Technology

21. IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation

22. Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen‐induced allergic asthma in a murine model

23. Anterior Nares Diversity and Pathobionts Represent Sinus Microbiome in Chronic Rhinosinusitis

24. Patient advisory board for chronic rhinosinusitis : a EUFOREA initiative

25. Real-life study showing better control of allergic rhinitis by immunotherapy than regular pharmacotherapy

26. New insights in neutrophilic asthma

27. AQUA((c)) Questionnaire as prediction tool for atopy in young elite athletes

28. Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology

29. Probiotics against airway allergy: host factors to consider

30. 1097 Importance of skin exposure in a sub-chronic mouse model of chemical-induced asthma

31. Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden

32. Assessing patient-reported outcomes in asthma and COPD patients: Which can be recommended in clinical practice?

33. Methylisothiazolinone: Dermal and respiratory immune responses in mice

34. An outbreak of swimming-pool related respiratory symptoms: An elusive source of trichloramine in a municipal indoor swimming pool

35. Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications

36. Endotype-driven treatment in chronic upper airway diseases

37. Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps

38. Forced expiration measurements in mouse models of obstructive and restrictive lung diseases

39. Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients

40. Allergy in severe asthma

41. Low cord blood Foxp3/CD3γ mRNA ratios: a marker of increased risk for allergy development

42. Early-onset airway damage in early-career elite athletes: A risk factor for exercise-induced bronchoconstriction

43. The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: A case-control analysis

44. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease

45. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

46. Pepsin and bile acids in induced sputum of chronic cough patients

47. Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course

48. Feasibility to apply eucapnic voluntary hyperventilation in young elite athletes

49. Toluene diisocyanate and methylene diphenyl diisocyanate: asthmatic response and cross-reactivity in a mouse model

50. Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers

Catalog

Books, media, physical & digital resources